{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:55:39Z","timestamp":1789811739034,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T00:00:00Z","timestamp":1354838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/cdd.2012.154","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T10:04:08Z","timestamp":1354874648000},"page":"567-575","source":"Crossref","is-referenced-by-count":30,"title":["Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors"],"prefix":"10.1038","volume":"20","author":[{"given":"T","family":"Montero-Melendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Perretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,7]]},"reference":[{"key":"BFcdd2012154_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R . Origin and physiological roles of inflammation. Nature 2008; 454: 428\u2013435.","journal-title":"Nature"},{"key":"BFcdd2012154_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A . Nonresolving inflammation. Cell 2010; 140: 871\u2013882.","journal-title":"Cell"},{"key":"BFcdd2012154_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/sj.cdd.4401695","volume":"12","author":"I Dransfield","year":"2005","unstructured":"Dransfield I, Rossi AG, Brown SB, Hart SP . Neutrophils: dead or effete? Cell surface phenotype and implications for phagocytic clearance. Cell Death and Differ 2005; 12: 1363\u20131367.","journal-title":"Cell Death and Differ"},{"key":"BFcdd2012154_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/35037722","volume":"407","author":"J Savill","year":"2000","unstructured":"Savill J, Fadok V . Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784\u2013788.","journal-title":"Nature"},{"key":"BFcdd2012154_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tips.2008.03.002","volume":"29","author":"JM Hallett","year":"2008","unstructured":"Hallett JM, Leitch AE, Riley NA, Duffin R, Haslett C, Rossi AG . Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci 2008; 29: 250\u2013257.","journal-title":"Trends Pharmacol Sci"},{"key":"BFcdd2012154_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1468","volume":"12","author":"AG Rossi","year":"2006","unstructured":"Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006; 12: 1056\u20131064.","journal-title":"Nat Med"},{"key":"BFcdd2012154_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd1383","volume":"3","author":"DW Gilroy","year":"2004","unstructured":"Gilroy DW, Lawrence T, Perretti M, Rossi AG . Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Disc 2004; 3: 401\u2013416.","journal-title":"Nat Rev Drug Disc"},{"key":"BFcdd2012154_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan CN, Savill J . Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6: 1191\u20131197.","journal-title":"Nat Immunol"},{"key":"BFcdd2012154_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313: 1929\u20131935.","journal-title":"Science"},{"key":"BFcdd2012154_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb J . The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007; 7: 54\u201360.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd2012154_CR11","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011; 3: 96ra77.","journal-title":"Sci Transl Med"},{"key":"BFcdd2012154_CR12","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","volume":"3","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011; 3: 96ra76.","journal-title":"Sci Transl Med"},{"key":"BFcdd2012154_CR13","doi-asserted-by":"publisher","first-page":"96ps35","DOI":"10.1126\/scitranslmed.3001512","volume":"3","author":"YA Lussier","year":"2011","unstructured":"Lussier YA, Chen JL . The emergence of genome-based drug repositioning. Sci Transl Med 2011; 3: 96ps35.","journal-title":"Sci Transl Med"},{"key":"BFcdd2012154_CR14","volume-title":"Leukemia","author":"DJ Stumpel","year":"2011","unstructured":"Stumpel DJ, Schneider P, Seslija L, Osaki H, Williams O, Pieters R et al. Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia. Leukemia. Leukemia Research Fund: UK, 2011."},{"key":"BFcdd2012154_CR15","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1182\/blood-2007-11-126003","volume":"111","author":"DC Hassane","year":"2008","unstructured":"Hassane DC, Guzman ML, Corbett C, Li X, Abboud R, Young F et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 2008; 111: 5654\u20135662.","journal-title":"Blood"},{"key":"BFcdd2012154_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, Rodina A et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 2006; 10: 321\u2013330.","journal-title":"Cancer Cell"},{"key":"BFcdd2012154_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","volume":"10","author":"G Wei","year":"2006","unstructured":"Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006; 10: 331\u2013342.","journal-title":"Cancer Cell"},{"key":"BFcdd2012154_CR18","doi-asserted-by":"publisher","first-page":"e18278","DOI":"10.1371\/journal.pone.0018278","volume":"6","author":"Z Wen","year":"2011","unstructured":"Wen Z, Wang Z, Wang S, Ravula R, Yang L, Xu J et al. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PloS One 2011; 6: e18278.","journal-title":"PloS One"},{"key":"BFcdd2012154_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri2470","volume":"9","author":"M Perretti","year":"2009","unstructured":"Perretti M, D'Acquisto F . Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9: 62\u201370.","journal-title":"Nat Rev Immunol"},{"key":"BFcdd2012154_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/157489211793980088","volume":"6","author":"V Carafa","year":"2011","unstructured":"Carafa V, Nebbioso A, Altucci L . Histone deacetylase inhibitors: recent insights from basic to clinical knowledge & patenting of anti-cancer actions. Recent Pat Anticancer Drug Discov 2011; 6: 131\u2013145.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"BFcdd2012154_CR21","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","volume":"23","author":"WK Kelly","year":"2005","unstructured":"Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T et al. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J Clin Oncol 2005; 23: 3923\u20133931.","journal-title":"J Clin Oncol"},{"key":"BFcdd2012154_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/icb.2011.92","volume":"90","author":"BA Suliman","year":"2011","unstructured":"Suliman BA, Xu D, Williams BR . HDACi: molecular mechanisms and therapeutic implications in the innate immune system. Immunol Cell Biol 2011; 90: 23\u201332.","journal-title":"Immunol Cell Biol"},{"key":"BFcdd2012154_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","volume":"32","author":"MR Shakespear","year":"2011","unstructured":"Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ . Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 2011; 32: 335\u2013343.","journal-title":"Trends Immunol"},{"key":"BFcdd2012154_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.33382","volume":"64","author":"J Gillespie","year":"2011","unstructured":"Gillespie J, Savic S, Wong C, Hempshall A, Inman M, Emery P et al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel HDAC3-selective inhibitor reduces IL-6 production by PBMC of RA patients. Arthritis and Rheum 2011; 64: 418\u2013422.","journal-title":"Arthritis and Rheum"},{"key":"BFcdd2012154_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.2011.154211","volume":"71","author":"AM Grabiec","year":"2011","unstructured":"Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA . Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann Rheum Dis 2011; 71: 424\u2013431.","journal-title":"Ann Rheum Dis"},{"key":"BFcdd2012154_CR26","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.176.8.5015","volume":"176","author":"R Glauben","year":"2006","unstructured":"Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F et al. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 2006; 176: 5015\u20135022.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR27","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 4123\u20134128.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFcdd2012154_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2119\/molmed.2011.00022","volume":"17","author":"TA McKinsey","year":"2011","unstructured":"McKinsey TA . Targeting inflammation in heart failure with histone deacetylase inhibitors. Mol Med 2011; 17: 434\u2013441.","journal-title":"Mol Med"},{"issue":"9","key":"BFcdd2012154_CR29","doi-asserted-by":"publisher","first-page":"e12771","DOI":"10.1371\/journal.pone.0012771","volume":"5","author":"Derek Renshaw","year":"2010","unstructured":"Renshaw D, Montero-Melendez T, Dalli J, Kamal A, Brancaleone V, D'Acquisto F et al. Downstream gene activation of the receptor ALX by the agonist annexin A1. PloS one 2010; 5.","journal-title":"PLoS ONE"},{"key":"BFcdd2012154_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/sj.cdd.4402139","volume":"14","author":"Y Tabe","year":"2007","unstructured":"Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S et al. Novel role of HDAC inhibitors in AML1\/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death and Differ 2007; 14: 1443\u20131456.","journal-title":"Cell Death and Differ"},{"key":"BFcdd2012154_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ejca.2008.01.023","volume":"44","author":"A Petrella","year":"2008","unstructured":"Petrella A, D'Acunto CW, Rodriquez M, Festa M, Tosco A, Bruno I et al. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. Eur J Cancer 2008; 44: 740\u2013749.","journal-title":"Eur J Cancer"},{"key":"BFcdd2012154_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2010.02.016","volume":"295","author":"CW D'Acunto","year":"2010","unstructured":"D'Acunto CW, Fontanella B, Rodriquez M, Taddei M, Parente L, Petrella A . Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1. Cancer Lett 2010; 295: 85\u201391.","journal-title":"Cancer Lett"},{"key":"BFcdd2012154_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nut.2009.07.006","volume":"26","author":"M Aoyama","year":"2010","unstructured":"Aoyama M, Kotani J, Usami M . Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways. Nutrition 2010; 26: 653\u2013661.","journal-title":"Nutrition"},{"key":"BFcdd2012154_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503\u2013511.","journal-title":"Nature"},{"key":"BFcdd2012154_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van 't Veer","year":"2002","unstructured":"van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530\u2013536.","journal-title":"Nature"},{"key":"BFcdd2012154_CR36","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","volume":"68","author":"T Bonome","year":"2008","unstructured":"Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 2008; 68: 5478\u20135486.","journal-title":"Cancer Res"},{"key":"BFcdd2012154_CR37","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.052702999","volume":"99","author":"F Leoni","year":"2002","unstructured":"Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 2995\u20133000.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFcdd2012154_CR38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1096\/fj.02-0941fje","volume":"17","author":"E Solito","year":"2003","unstructured":"Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M . A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 2003; 17: 1544\u20131546.","journal-title":"FASEB J"},{"key":"BFcdd2012154_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjp.0706730","volume":"148","author":"S Yona","year":"2006","unstructured":"Yona S, Heinsbroek SE, Peiser L, Gordon S, Perretti M, Flower RJ . Impaired phagocytic mechanism in annexin 1 null macrophages. Br J Pharmacol 2006; 148: 469\u2013477.","journal-title":"Br J Pharmacol"},{"key":"BFcdd2012154_CR40","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.4049\/jimmunol.178.7.4595","volume":"178","author":"M Scannell","year":"2007","unstructured":"Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 2007; 178: 4595\u20134605.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR41","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.4049\/jimmunol.0902250","volume":"183","author":"KE Blume","year":"2009","unstructured":"Blume KE, Soeroes S, Waibel M, Keppeler H, Wesselborg S, Herrmann M et al. Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis. J Immunol 2009; 183: 8138\u20138147.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR42","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1083\/jcb.201004096","volume":"189","author":"MR Elliott","year":"2010","unstructured":"Elliott MR, Ravichandran KS . Clearance of apoptotic cells: implications in health and disease. J Cell Biol 2010; 189: 1059\u20131070.","journal-title":"J Cell Biol"},{"key":"BFcdd2012154_CR43","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1096\/fj.11-0502ufm","volume":"25","author":"CN Serhan","year":"2011","unstructured":"Serhan CN . The resolution of inflammation: the devil in the flask and in the details.. FASEB J 2011; 25: 1441\u20131448.","journal-title":"FASEB J"},{"key":"BFcdd2012154_CR44","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.4049\/jimmunol.1003145","volume":"186","author":"V Brancaleone","year":"2011","unstructured":"Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M . Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2\/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol 2011; 186: 4905\u20134914.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR45","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1182\/blood-2005-08-3099","volume":"107","author":"RP Hayhoe","year":"2006","unstructured":"Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M . Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006; 107: 2123\u20132130.","journal-title":"Blood"},{"key":"BFcdd2012154_CR46","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1096\/fj.10-159913","volume":"24","author":"P Maderna","year":"2010","unstructured":"Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M et al. FPR2\/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J 2010; 24: 4240\u20134249.","journal-title":"FASEB J"},{"key":"BFcdd2012154_CR47","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","volume":"174","author":"GL Bannenberg","year":"2005","unstructured":"Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005; 174: 4345\u20134355.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR48","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.176.7.4410","volume":"176","author":"AS Damazo","year":"2006","unstructured":"Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM . Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol 2006; 176: 4410\u20134418.","journal-title":"J Immunol"},{"key":"BFcdd2012154_CR49","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature05877","volume":"447","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, Serhan CN . Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007; 447: 869\u2013874.","journal-title":"Nature"},{"key":"BFcdd2012154_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1189\/jlb.0809540","volume":"87","author":"LP Sousa","year":"2010","unstructured":"Sousa LP, Lopes F, Silva DM, Tavares LP, Vieira AT, Rezende BM et al. PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K\/Akt-dependent and NF-kappaB-independent manner. J Leukoc Biol 2010; 87: 895\u2013904.","journal-title":"J Leukoc Biol"},{"key":"BFcdd2012154_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1189\/jlb.0112008","volume":"92","author":"JP Vago","year":"2012","unstructured":"Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 2012; 92: 249\u2013258.","journal-title":"J Leukoc Biol"},{"key":"BFcdd2012154_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/emmm.201000113","volume":"3","author":"D Pupjalis","year":"2011","unstructured":"Pupjalis D, Goetsch J, Kottas DJ, Gerke V, Rescher U . Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK\/STAT\/SOCS signalling. EMBO Mol Med 2011; 3: 102\u2013114.","journal-title":"EMBO Mol Med"},{"key":"BFcdd2012154_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.joca.2007.10.014","volume":"16","author":"Y Nasu","year":"2008","unstructured":"Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, Abe N et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis and cartilage\/OARS. Osteoarthritis Cartilage 2008; 16: 723\u2013732.","journal-title":"Osteoarthritis Cartilage"},{"key":"BFcdd2012154_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1096\/fj.02-0239fje","volume":"17","author":"R Hannon","year":"2003","unstructured":"Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, Paul-Clark MJ et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1\u2212\/\u2212 mouse. FASEB J 2003; 17: 253\u2013255.","journal-title":"FASEB J"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2012154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2012154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2012154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:02:08Z","timestamp":1684414928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2012154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFcdd2012154"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2012.154","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,7]]}}}